2,3,6-trimethyl-1,4-naphthoquinone has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castagnoli, KP; Castagnoli, N; Petzer, JP; Steyn, SJ; Van der Schyf, CJ | 1 |
1 other study(ies) available for 2,3,6-trimethyl-1,4-naphthoquinone and Disease Models, Animal
Article | Year |
---|---|
Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Naphthoquinones; Neostriatum; Neuroprotective Agents; Nicotiana; Parkinsonian Disorders; Plant Extracts; Plants, Toxic | 2001 |